Index of artpub/2022/pmc_35205662/

Poveda, Andres
Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors : Results of Efficacy, Tolerability, and the Translational Study
2022
https://ddd.uab.cat/record/256101